| Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 15.04 mm | 15.04 mm | 15.04 mm | 15.04 mm | 15.04 mm | 15.04 mm |
| Cash burn (monthly) | 1.48 mm | 1.24 mm | 1.83 mm | 3.41 mm | 1.46 mm | 2.63 mm |
| Cash used (since last report) | 29.70 mm | 24.84 mm | 36.79 mm | 68.50 mm | 29.31 mm | 52.78 mm |
| Cash remaining | -14.67 mm | -9.80 mm | -21.75 mm | -53.46 mm | -14.28 mm | -37.75 mm |
| Runway (months of cash) | -9.9 | -7.9 | -11.9 | -15.7 | -9.8 | -14.4 |
| 13F holders | Current |
|---|---|
| Total holders | 2 |
| Opened positions | 1 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 9.97 mm |
| Total shares | 34.24 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Ally Bridge Group-WTT Global Life Science Capital Partners | 34.24 mm | $9.97 mm |
| Ameriflex | 62.00 | $0.00 |
